Dysregulation of sphingolipid metabolism in cancer
- PMID: 21209555
- DOI: 10.4161/cbt.11.2.14624
Dysregulation of sphingolipid metabolism in cancer
Abstract
Altered sphingolipid metabolism contributes to cancer progression and presents an exploitable _target for the development of novel chemotherapeutics. Bioactive sphingolipid metabolites also have the potential to serve as vital biomarkers for cancer and be utilized to determine disease progression, as well as guide therapeutic regimens. Moreover, identification of these sphingolipid biomarkers is achievable based on recent technological advances in sphingolipidomics, which have aided in detection of sphingolipid metabolites through tools like mass spectrometry. Excellent reviews have previously focused on the biochemical role that sphingolipids have in cancer pathogenesis and treatment. The aim of this review is to concentrate on the critical metabolites and enzymes that contribute to the dysregulation in sphingolipid metabolism, and highlight relevant translational research that is directed towards novel therapies.
Similar articles
-
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.Adv Cancer Res. 2018;140:327-366. doi: 10.1016/bs.acr.2018.04.016. Epub 2018 Jun 19. Adv Cancer Res. 2018. PMID: 30060815 Free PMC article. Review.
-
Sphingolipid modulation: a strategy for cancer therapy.Anticancer Agents Med Chem. 2012 May;12(4):285-302. doi: 10.2174/187152012800228643. Anticancer Agents Med Chem. 2012. PMID: 21864240 Review.
-
Sphingolipid-Transporting Proteins as Cancer Therapeutic _targets.Int J Mol Sci. 2019 Jul 20;20(14):3554. doi: 10.3390/ijms20143554. Int J Mol Sci. 2019. PMID: 31330821 Free PMC article. Review.
-
Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.Chem Phys Lipids. 2012 May;165(4):462-74. doi: 10.1016/j.chemphyslip.2012.02.006. Epub 2012 Feb 23. Chem Phys Lipids. 2012. PMID: 22387097 Review.
-
Sphingolipids in cancer: regulation of pathogenesis and therapy.FEBS Lett. 2006 Oct 9;580(23):5467-76. doi: 10.1016/j.febslet.2006.08.052. Epub 2006 Sep 5. FEBS Lett. 2006. PMID: 16970943 Review.
Cited by
-
Rapid and comprehensive 'shotgun' lipidome profiling of colorectal cancer cell derived exosomes.Methods. 2015 Oct 1;87:83-95. doi: 10.1016/j.ymeth.2015.04.014. Epub 2015 Apr 20. Methods. 2015. PMID: 25907253 Free PMC article.
-
Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity.Cell Biosci. 2022 Oct 8;12(1):169. doi: 10.1186/s13578-022-00900-9. Cell Biosci. 2022. PMID: 36209197 Free PMC article.
-
Ceramide Kinase (CERK) Emerges as a Common Therapeutic _target for Triple Positive and Triple Negative Breast Cancer Cells.Cancers (Basel). 2022 Sep 16;14(18):4496. doi: 10.3390/cancers14184496. Cancers (Basel). 2022. PMID: 36139656 Free PMC article.
-
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR.Int J Mol Sci. 2023 Oct 20;24(20):15394. doi: 10.3390/ijms242015394. Int J Mol Sci. 2023. PMID: 37895074 Free PMC article.
-
Sphingomyelinases and Liver Diseases.Biomolecules. 2020 Oct 30;10(11):1497. doi: 10.3390/biom10111497. Biomolecules. 2020. PMID: 33143193 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
